SENTI BIOSCIENCES HOLDINGS I (SNTI:NASDAQ)

$0.9612 -0.0233 (-2.3667%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 81

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed SENTI BIOSCIENCES HOLDINGS I (SNTI:NASDAQ) News Sources

Senti Biosciences Completes Enrollment in Phase 1 Clinical Trial of SENTI-202 for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia (R/R AML)

11-02-2026

yahoo.com

Senti Bio Participates in Cell & Gene Live Event Highlighting Cutting-Edge Technologies Advancing Cell Therapy Development

20-02-2026

yahoo.com

Senti Biosciences to Present at TD Cowen 46th Annual Health Care Conference

24-02-2026

yahoo.com

Senti Biosciences to Present at Leerink Partners 2026 Global Healthcare Conference

03-03-2026

yahoo.com

Senti Biosciences to Present Clinical and Translational Data on SENTI-202 at the 11th Annual Innate Killer Conference

23-03-2026

yahoo.com

Senti Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides a Corporate Update

27-03-2026

yahoo.com

Senti Biosciences Announces Publication in Cell Systems Demonstrating Advanced Logic-Gated CAR Design for Cell Therapies

01-04-2026

yahoo.com

Senti Biosciences to Present on Logic-Gated Cell Therapies in Educational Session at AACR Annual Meeting 2026

13-04-2026

yahoo.com

Senti Biosciences Holdings Announces Positive FDA RMAT Meeting on Registrational Clinical and CMC Strategy for SENTI-202 in Relapsed/Refractory AML, Along with Important Efficacy and Durability Updates on the SENTI-202 Clinical Program

14-05-2026

yahoo.com

Senti Biosciences Holdings Reports First Quarter 2026 Financial Results and Highlights Advancement of SENTI-202 Program into Pivotal Phase

14-05-2026

yahoo.com

SENTI BIOSCIENCES HOLDINGS I (SNTI:NASDAQ) Sentiment Trend

0 25 50 75 100 77 84 85 86 87 88 74 87 70 74 11-02-2026 20-02-2026 24-02-2026 03-03-2026 23-03-2026 27-03-2026 01-04-2026 13-04-2026 14-05-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

SENTI BIOSCIENCES HOLDINGS I (SNTI:NASDAQ) FAQs

toggle

What is the current price of SENTI BIOSCIENCES HOLDINGS I (SNTI:NASDAQ)?

The current price of SENTI BIOSCIENCES HOLDINGS I (SNTI:NASDAQ) is $0.9612.


toggle

SENTI BIOSCIENCES HOLDINGS I (SNTI:NASDAQ) absolute price change since previous trading day?

The absolute price change of SENTI BIOSCIENCES HOLDINGS I (SNTI:NASDAQ) since the previous trading day is $-0.0233.


toggle

SENTI BIOSCIENCES HOLDINGS I (SNTI:NASDAQ) percentage price change since previous trading day?

The percentage price change of SENTI BIOSCIENCES HOLDINGS I (SNTI:NASDAQ) since the previous trading day is -2.3667%.


toggle

What is the most recent average sentiment score for SENTI BIOSCIENCES HOLDINGS I (SNTI:NASDAQ)?

The most recent average sentiment score for SENTI BIOSCIENCES HOLDINGS I (SNTI:NASDAQ) is 81 out of 100.


toggle

What is the most recent average sentiment for SENTI BIOSCIENCES HOLDINGS I (SNTI:NASDAQ)?

The most recent sentiment for SENTI BIOSCIENCES HOLDINGS I (SNTI:NASDAQ) is .


SEC-8K** Filing Available For SENTI BIOSCIENCES HOLDINGS I (SNTI:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.